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Abstract
Background: The availability of the P. falciparum genome has led to novel ways to identify potential vaccine candidates. A
new approach for antigen discovery based on the bioinformatic selection of heptad repeat motifs corresponding to a-
helical coiled coil structures yielded promising results. To elucidate the question about the relationship between the coiled
coil motifs and their sequence conservation, we have assessed the extent of polymorphism in putative a-helical coiled coil
domains in culture strains, in natural populations and in the single nucleotide polymorphism data available at PlasmoDB.
Methodology/Principal Findings: 14 a-helical coiled coil domains were selected based on preclinical experimental
evaluation. They were tested by PCR amplification and sequencing of different P. falciparum culture strains and field isolates.
We found that only 3 out of 14 a-helical coiled coils showed point mutations and/or length polymorphisms. Based on
promising immunological results 5 of these peptides were selected for further analysis. Direct sequencing of field samples
from Papua New Guinea and Tanzania showed that 3 out of these 5 peptides were completely conserved. An in silico
analysis of polymorphism was performed for all 166 putative a-helical coiled coil domains originally identified in the P.
falciparum genome. We found that 82% (137/166) of these peptides were conserved, and for one peptide only the detected
SNPs decreased substantially the probability score for a-helical coiled coil formation. More SNPs were found in arrays of
almost perfect tandem repeats. In summary, the coiled coil structure prediction was rarely modified by SNPs. The analysis
revealed a number of peptides with strictly conserved a-helical coiled coil motifs.
Conclusion/Significance: We conclude that the selection of a-helical coiled coil structural motifs is a valuable approach to
identify potential vaccine targets showing a high degree of conservation.
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Introduction
The majority of known malaria antigens are highly polymorphic
[1]. Tandem repeats are found in central domains of many
antigens giving rise to extensive length polymorphism (LP) [2]. In
addition, single nucleotide polymorphisms (SNPs) are abundant in
antigenic genes, with 65% of SNPs on a genome-wide scale being
non-synonymous (i.e the nucleotide substitution results in an
amino acid change) [3]. The genetic diversity of new vaccine
candidates is generally determined in the preclinical characteriza-
tion of the candidate. High levels of polymorphism in malaria
antigens are thought to be part of the parasite’s strategy to avoid
destruction by the host’s immune defense. By including polymor-
phic sequences in a malaria vaccine, variant-specific immune
responses will be elicited. As a consequence, alleles distinct form
the vaccine molecule will be favored by selective advantage giving
rise to escape variants. This situation was observed by molecular
and immunological monitoring in the Phase I/IIb trial of the
malaria vaccine Combination B that, in addition to two other
components, contained almost the full length of merozoite surface
protein 2 (MSP2) allele of the 3D7 cloned parasite line [4]. In
vaccine recipients, a lower prevalence of the 3D7-type genotype
was observed and genotypes belonging to the alternative allelic
family were responsible for a higher incidence of malaria episodes
[5]. A significant strain-specific humoral response was directed
against the repetitive and family-specific MSP2 domains, whereas
only low antibody titres were observed against conserved domains
of MSP2 [6]. Similarly, a strain-specific response was observed in a
challenge trial in Aotus monkeys with the two alleles of MSP142
[7]. There are also contrasting findings from clinical trial of RTS,S
where no selection was observed in break-through infections for
SNPs in the circumsporozoite protein T-cell-epitope regions [8].
The question remains whether the inclusion of more than one
allelic form of an antigen can compensate substantial polymor-
phism [9]. As for MSP2, the inclusion of two variants into a
vaccine has been proposed for MSP3 [6,10]. So far there is little
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morbidity in contrast to single antigen vaccines [4]. An other
interesting aspect in immune evasion is that naturally occurring
variants of the same epitope can prevent memory T cells effector
functions referred as ‘‘altered peptide ligand’’ antagonism [11,12].
The above examples highlight a major obstacle for vaccine
development posed by polymorphism in vaccine candidates. By
using non-polymorphic domains of antigens, selection of vaccine
escape variants could be avoided. A further important consider-
ation in vaccine development is the complexity of candidate
molecules in the vaccine formulation. If more variants are required
in order to cover the major alleles found world-wide, highly
complex mixtures, particularly for multi-component vaccines,
would result; thus risking high costs and potential antagonistic
effects [4].
Our approach to discover novel vaccine candidates is based
on the selection of protein segments with defined structural
motifs, with emphasis on identifying conserved domains of
antigens. A genome-wide bioinformatic approach was taken to
identify potential candidates that contain an a-helical coiled
coil motif [13]. The a-helical coiled coils share a (abcdefg)n
motif containing hydrophobic residues at positions a and d and
generally polar in the remaining positions. Chemically synthe-
sized short peptides consisting of this motif can fold into their
native structure. This is an appealing characteristic and
represents a new approach to malaria vaccine development.
The use of synthetic peptides over recombinantly expressed
proteins in vaccines is advantageous because no expression or
elaborate purification system is required, making the develop-
ment process much less tedious and time consuming [14]. A
further advantage of a-helical coiled coil motifs is that they are
recognized by conformational dependent antibodies [15]. These
coiled coil motifs are highly abundant in the eukaryotic cell.
They are found in about 10% of all protein sequences [16].
This widespread occurrence in nature is explained by the broad
range of function pertaining to the specific design of their
coiled coil domains [17]. The crucial biological function of this
domain has been investigated in numerous proteins. Generally,
a-helical coiled coil domains serve as oligomerization motifs in
proteins.
The rationale for our focus on peptides with little or no
polymorphism was that these coiled coil regions were immuno-
genic in mice and well recognized by naturally occurring
antibodies [13] (Olugbile et al., manuscript in preparation). In
addition, affinity purified antibodies against these peptides killed
parasites in vitro as shown by an assay involving antibody-
dependent cellular inhibition [13,18,19]. Presence of hydrophobic
residues in a and d positions is important for formation of the
critical interhelical interactions while mostly hydrophilic residues
in the remaining positions are exposed on the surface of the a-
helical coiled coil motif and assumed to function as sites for protein
interaction. Such structural and functional constraints associated
with coiled coil domains likely signify these motifs are under
purifying selection and led us to expect and investigate sequence
conservation.
In an attempt to elucidate the relationship between coiled coil
structure and sequence conservation, we analyzed the polymor-
phism in 166 synthetic peptides, previously identified in a genome-
wide selection process [13]. Many of these molecules have
undergone immunological testing [13] and some have successfully
entered the vaccine development pipeline. 14 peptides included in
the analysis were further assessed in 13 culture strains. The
sequence diversity of 5 of these 14 peptides was also investigated in
parasite populations from endemic countries.
Materials and Methods
Ethics Statement
Research clearance for blood sampling and genetic analysis of
parasites was granted by the Tanzanian Commission for Science
and Technology and by the Medical Research and Advisory
Committee of the Ministry of Health in Papua New Guinea.
Parasite culture
The culture strains were grown in 10 cm Petri dishes and
cultured by standard methods in an atmosphere of 93% N2,4 %
CO2,3 %O 2 at 37uC as described previously [20]. The culture
medium was RPMI 1640 10.44 g/L, supplemented with Hepes
5.94 g/L, Albumax II 5 g/L, hypoxanthine 50 mg/L, sodium
bicarbonate 2.1 g/L and neomycin 100 mg/L.
Polymorphism study in culture strains
Genetic diversity of 14 peptides spanning the a-helical coiled
coil region of 10 hypothetical proteins was assessed in 13 in vitro
culture strains (3D7, W2mef, HB3, ITG2F6, IFA18, FVO, 7G8,
K1, RO33, MAD20, FCR3, RFCR3 and FC27). The geograph-
ical origin of each strain is listed in Table 1. Genomic DNA was
isolated with phenol/chloroform extraction. PCR primers used to
amplify the a-helical coiled-coil region are listed in Table S1.6 3
blood samples derived from 1–5 year old children from Ifakara,
Tanzania with uncomplicated acute malaria. These samples were
collected in the course of an antimalarial drug trial [21]. 19
samples were asymptomatic community samples from Mugil
village, Papua New Guinea [22]. Genomic DNA was isolated with
phenol/chloroform extraction or the QIAamp DNA Blood Mini
Kit 250 (Qiagen). PCR conditions consisted of denaturation at
94uC for 5 min followed by 35 cycles of denaturation (94uC for
1 min), annealing (50uC for 1 min) and extension (72uC for
1 min). The reaction products were incubated at 72uC for 10 min
to ensure complete DNA extension. The PCR products were
directly sequenced and aligned using Auto Assembler software to
screen for SNPs and LP within the sequences corresponding to the
peptides.
Table 1. Origin of culture strains.
culture strain origin
3D7 Airport malaria (Amsterdam)
FC27 Madang, PNG
MAD20 PNG
RFCR3 Gambia
FCR3 Gambia
W2mef Indochina
K1 Thailand
Hb3 Honduras
IFA18 Ifakara, Tanzania
RO-33 Ghana
ITG2F6 Brazil
FVO Vietnam
7G8 Brazil
doi:10.1371/journal.pone.0005419.t001
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Due to large introns in the genomic DNA corresponding to P38
and P77 cDNA was produced for sequencing of the 13 culture
strains (3D7, W2mef, HB3, ITG2F6, IFA18, FVO, 7G8, K1,
RO33, MAD20, FCR3, RFCR3 and FC27). 10 ml of parasite
culture of 5% mixed stage parasites were lysed in 3 ml of Trizol
(Invitrogen) and RNA was extracted with 0.2 volumes of
chloroform and precipitated with 0.8 volumes of isopropanol.
The extraction was repeated in half of the original Trizol volume
to reduce contamination with gDNA. Residual gDNA was
digested twice with RQ1 Dnase (Promega) according to the
manufacturer’s protocol in a total volume of 50 ml. RNA was
dissolved in 25 ml of 5 mM Tris/0.5 mM EDTA and 9.5 ml RNA
was used for the reverse transcription by AffinityScript Multiple
Temperature Reverse Transcriptase (Stratagene) with random
primers (Invitrogen) as described by the manufacturer. P38 and
P77 sequences were amplified from cDNA with Advantage cDNA
polymerase (BD Biosciences) using the primers listed in Table S1.
To determine gDNA contamination the corresponding peptide
sequences were amplified with Advantage Taq from RNA
processed simultaneously without the addition of reverse tran-
scriptase.
Identification of a-helical coiled coil motif
For the original genome-wide selection of coiled coil domains,
we generated 25 residues-long,-helical coiled coil profiles [13] by
using pftools package [23]. This profile was constructed by using a
multiple alignment of amino acid sequences corresponding to the
known a-helical coiled coil domains found in the Protein Data
Bank (PDB) [24], release 2006. In this work, the profile was
updated by adding new sequences of the known coiled coil
structures from PDB (release 2008). The score of this profile
reflects the level of similarity of an analyzed amino acid sequence
to the typical coiled coil motif which was deduced from the
alignment of the known coiled coils. Tests of this profile against a
sequence database of proteins with the known 3D structures
showed that (1) the scores above 3.0 corresponded exclusively to
coiled coil structures; (2) some coiled coil structures may have
scores above 2.1. The 2.1 cut-off level was chosen for the first stage
of the identification procedure to include most of the putative
coiled coils. Subsequently, the selected coiled coil regions were
tested manually for the presence of the characteristic heptad
repeats. Although all putative a-helical coiled coil domains
identified in the P. falciparum genome share the heptad repeat
sequence motif, they can be distinguished by fidelity of the heptad
repetitions. We subdivided the analyzed coiled coil regions into
two groups. The first group contains peptides with perfect, or, in
case of one or more SNPs, almost perfect tandem repetition of a
certain sequence motif. The length of the perfect repeat either
coincides with the length of the 7 residue coiled coil repeat or is
divisible by 7. The second group of imperfect repeats is
characterized by the repetition of amino acid residues with similar
physico-chemical properties rather than by repeat units of exactly
the same amino acid residues. Both types of repeats contain
hydrophobic residues at positions a and d of the heptads and polar
residues in the remaining positions. In this work, we assed the
extend of polymorphism in the identified a-helical coiled coil
domains and examined the polymorphism in perfect or almost
perfect repeats as opposed to that in imperfect repeats.
Results
The extensive genetic diversity of blood stage antigens is one of
the key challenges in vaccine development against malaria. After
the selection of 166 novel blood stage vaccine candidates, all
harbouring a-helical coiled coil motif, we undertook a compre-
hensive in silico analysis of these domains. In addition, we
performed an in depth molecular epidemiological analysis on
selected peptides that proved to be the most promising vaccine
candidates according to an immunological evaluation process [13].
SNP data for a maximum of 15 P. falciparum culture strains are
currently available in the PlasmoDB 5.4 database (http://
PlasmoDB.org), the official database of the P. falciparum genome
sequencing consortium. Unfortunately, PlasmoDB 5.4 does not
incorporate information on insertions or deletions. Nevertheless,
insertions and deletions are thought to provide as much diversity
as SNPs in P. falciparum [25]. In order to determine the full extent
of diversity in recently identified vaccine candidates [13], we have
analyzed the polymorphism of the selected a-helical coiled coil
regions in 13 different culture strains and in cross sectional field
samples from malaria endemic regions. Direct sequencing made it
possible to detect both, SNP and LP.
Genetic Diversity in in vitro culture strains of P. falciparum
Table 1 lists the 13 strains that were analyzed for SNPs and LP
by PCR and direct sequencing of the corresponding 14 most
promising peptides selected from the preclinical evaluations.
Primers used for PCR amplification and sequencing are listed in
Table S1. Polymorphism results are presented in Table 2.I n
addition we have included all information on polymorphism that is
publicly available at PlasmoDB 5.4. Peptides P1, P14 and P83
showed either LP alone (P1, Figure 1) or both types of
polymorphism, SNP plus LP (P14, Figure 2 and P83 Figure 3).
Peptides showing LP revealed tandem repeats and differed from
each other by 1 to 3 heptad repeat units. Therefore, these
mutations do not introduce a frame shift into the coiled coil motif.
For example, P83 corresponding to the a-helical coiled coil
domain of the gene product of PFC0345w shows a duplication of
the heptamer DMNIKEN between amino acids N276 and D277,
and was detected with a frequency of 0.31 (4/13) in 4 culture
strains (Table 2).
Some SNPs were prevalent in our culture strains. For P83 the
SNP at nt 863 TRA occurred with a frequency of 0.38 (5/13).
This SNP was also described in PlasmoDB 5.4 and was observed
with a frequency of 0.43 (6/14). Two additional SNPs were found
for P83. A GRA substitution at nt position 927 resulted in a non-
synonymous change from methionine (M) to isoleucine (I) at
amino acid 309. This SNP was only found once and only in our
culture strains. An additional SNP at nt position 999, arising from
an ARC conversion, results in an amino acid change from
glutamic acid (E) to aspartic acid (D), and was also found only
once. These SNPs were also reported in PlasmoDB. With respect
to the underlying heptad repeat positions labeled a to g, all SNPs
detected in P83 were at hydrophobic positions a and d, however,
these SNPs do not affect the coiled coil formation significantly and
the antibody epitopes on the surface of the coiled coil likely remain
conserved. It is worth mentioning that, in principle, one point
mutation can change the oligomerization state of the coiled coil.
However, the general rules governing the stoichiometry of the
coiled coil structures are still largely unknown. Due to the fact that
most of the observed non-synonymous SNPs represent change to
the residues with similar physico-chemical properties (e.g.
hydrophobic to hydrophobic), we assume that the oligomerization
states of the coiled coils also remain conserved. One SNP of P83
leads to a change of a hydrophobic methionine (M288) to a
charged lysine (K) in d-position of the heptamer unit underlying
coiled coil structural motifs (Table 2). The charged residue in d-
position favors a coiled coil dimer. However, we do not know the
Conserved Coiled Coils
PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5419Table 2. Genetic diversity in the 14 peptides sequences.
peptide
a
Gene ID
PlasmoDB 5.4
SNP data extracted from
PlasmoDB 5.4
SNPs detected by sequencing of
culture strains
b
position
type of
mutation
c-f frequency position
type of
mutation
c-f frequency
P1
BDDDDDDDDDDDDDDDDDDDDDA
G
BDDDDDDDDDDDDDDDDDD
VNNLDSTVNYMNSTGNNINNIVNNLDSTVNYMNSTGNN
abcdefgabcdefgabcdefgabcdefgabcdefabcd
DDDABDDD DDDDDDDDDDDDDDDDDDDA
I NNIVNNLDSTVNYMNSTGNNINNI
abcdefgabcdefgabcdefgabcd
PFA0170c nt 1525
ART
nt 1518
ARG
nt 1581
GRA
ns (S509G)
s
s
1/15
1/15
1/15
nt 1599
nt 1662
Del
Del
2/13
10/13
P2
T ISSLSNKIVNYESK IEELEKELKEVK
gabcdefgabcdefgabcdefgabcde
PFB0145c conserved conserved
P5
I IDI KKHLEKLKIE IKEKKEDLENL
abcdefgabcdefgabcdefgabcd
conserved conserved
P8
I KTMNTQISTLKNDVHLLNEQDKLNNEKGTLNSKISEL
abcdefgabcdefgabcdefgabcdefgabcdefabcd
NVQIMDL
efgabcd
conserved conserved
P9
LLSKDKEIEEKNKKIKELNNDIKKL
abcdefgabcdefgabcdefg abcd
conserved conserved
P13
LDENEDNIKKMKSKI DDMEKEIKYR
abcdefgabcdefgabcdefgabcd
conserved conserved
P14
BDDDDDDA
E
BD DDDDABDDDDDABDD DDDDABD DDDDDA
GMNNMNGDINNINGDINNMNGDINNMNGDINNMNGDIN
gabcdefg abcdefgabcdefg abcd efg abcdefg ab
NMN
cde
PFC0245c nt 6662
CRT
nt 6726
TRA
ns (G2221E)
s
1/10
1/8
nt 2227 Del
(GDINNMN)
7/13
P27
KKRNVEEELHSLRKNYNI I NEE IEEIT
gabcdefgabcdefgabcdefgabcde
PFF0165c conserved conserved
P35
ARDDIQKDINKMESELINVSNEINRLD
gabcdefgabcdefgabcdefg abcde
PF14_0045 conserved conserved
P38
NITNINKNIENIKNDMSNLNNMNDSNQ
gabcdefg abcdefgabcdefgabcde
PF14_0089 conserved conserved
P77
EKLKKYNNEISSLKKELDILNEKMGKCT
fgabcdefg abcdefgabcdefgabcde
PF08_0048 conserved conserved
P79
B DDDDDDABDD DDDABDD DDDABD DDDDABDDDDDAB
NEMNKEVNKMNEEVNKMNEEVNKMNEEVNKMNKEVNKM
bcd efgabcd efgabcdefgabcdefgabcd efabcde
DDDDDABDDDDDA
DEEVNKMNKEVNKMNK
fg abcdefg abcd efg
PFB0315w nt 4845
GRA
s 1/12 conserved
Conserved Coiled Coils
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impossible to conclude whether the M288K mutant indeed
changes the oligomerization state. Further experimental studies
are required to clarify the oligomerization state of P83 wildtype
and mutant.
Diversity in parasite populations
Five vaccine candidates, prioritized according to their
performance in immunological and functional assays, were
further analyzed in a small-scale molecular epidemiological
survey. The basis for selection and results of the preclinical
evaluation process were published previously [13,14]. The five
candidates were peptides P8, P27, P77, P83 and P90. In
addition to showing promising results, all were conserved or
showed limited polymorphism in culture strains (Table 2). The
extent of sequence conservation was determined in field samples
from two malaria endemic areas: Tanzania (TZ) and Papua New
Guinea (PNG) (Table 3). P27 and P77 were found to be
completely conserved. P90 is also conserved on the amino acid
level in 23 samples from TZ and 31 samples from PNG, with
only a synonymous SNP 195 ARG in samples from TZ with a
frequency of 0.17 (4/23). This SNP was also reported in
PlasmoDB 5.4 to occur in the GHANA1 strain (Table 2). The
P8 sequence was conserved in culture strains, but in the field
samples 2 SNPs were detected. 4 SNPs (SNP1-4) and 2 LP
(LPT2, LPT26) were detected for P83 in both populations
examined (Figure 4). Thus, in field samples 3/5 peptides
showed complete conservation on the amino acid level and only
minor polymorphism was observed for the remaining 2
candidates. This is in line with sequence diversity detected in
Figure 1. Alignment of P1 sequences amplified from 13 culture strains. Two types of deletions were detected in the PFA0170c gene: a
longer deletion (del1) between T1599 and T1726 and a shorter deletion (del2) T1662 and T1726. On the protein level del1 results in the loss of
NINNIVNNLDSTVNYMNSTGNNINNIVNNLDSTVNYMNSTGN amino acid motif between N533 and Y576 and del1 in the loss of NINNIVNNLDSTV-
NYMNSTGN between N554 and Y576 of P1. The peptide sequences P1 is indicated with bold letters. The heptad reapets are marked on top of the
alignment sequence as a repeated abcdefg motif in which the hydrophobic position a (bold) and d (bold) are highlighted.
doi:10.1371/journal.pone.0005419.g001
peptide
a
Gene ID
PlasmoDB 5.4
SNP data extracted from
PlasmoDB 5.4
SNPs detected by sequencing of
culture strains
b
position
type of
mutation
c-f frequency position
type of
mutation
c-f frequency
P83
BDDDDDA BD DDDDA
K
BD DDDDABD DDDDABDD
QNKMENDMNII KNDMNIMENDMNIMENDMNI IKNDMNI
abcdefga bcdefga bcdefga bcdefga bcdefabcd
D DDDA
I
BDDDDABDDDDDABD DDDDA
D
BDDDD DA
MEKDMNI I KNDMNI IKNNMNI I KNEMNI I KNV
abcdefg abcdefg abcdefg abcdefgabcd
PFC0345w nt 863
TRA
nt 927
GRA
nt 999
ARC
ns (M288K)
ns (M309I)
ns (E333D)
4/9
1/10
1/10
nt 863 TRA
nt 927 GRA
nt 999 ARC
nt 827
ns (M288K)
ns (M309I)
ns (E333D)
dup
(DMNIKEN)
5/13
1/13
1/13
4/13
P90
TKKLNKELSEGNKELEKLEKNIKELEETNNTLENDIKV
gabcdefgabcdefgabcdefgabcdefgabcdefgab
PFD0520c nt 195
ARG
s 1/9 conserved
aPeptide sequences are aligned with the coiled coil heptad repeat (abcdefg); lines with arrows over some sequences indicate tandem repeats.
bP. falciparum in vitro cultre strains 3D7, FC27, K1, IFA18, FV0, 7G8, HB3, ITG2F6, RO-33, W2mef, FCR3S1.2, RFCR3, MAD20
cnon synonymous (ns);
dsynonymous (s);
edeletion (del);
fduplication (dup).
doi:10.1371/journal.pone.0005419.t002
Table 2. cont.
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LP.
Effects of polymorphism on the probability of a-helical
coiled coil structure formation
A comprehensive in silico analysis was performed on 166 selected
coiled coil sequences to determine the effects of SNP and LP on
the probability to form an a-helical coiled coil. Our approach
allowed the prediction of structure modifications caused by the
known SNPs within our peptides, which are recorded in the SNP
database in PlasmoDB
Overall we detected a high degree of sequence conservation
in 166 predicted a-helical coiled coil domains. Only 29/166
peptides showed limited polymorphism. In one of the 29
polymorphic peptides the score fell below the cut-off (altered
score bolded in Table 4). In contrast to the above result on
P83 that had shown SNPs exclusively at hydrophobic residues,
the majority of the SNPs in the 166 peptides were found at the
surface positions b, c, e, f and g within the heptad repeat and
are unlikely to destabilize the coiled coil structures.
For peptides P17 and P23 -wild type (in culture strain 3D7;
Table 4), P17-mutant (in culture strain GHANA1), and P23-
mutant (in culture strain 7G8, FCB, K1, GHANA1; Table 4) the
length of the synthesized peptide was too short to be analyzed by
the 25 residue-long profile. These short peptides were then
analyzed manually and it was shown that mutations do not affect
the heptad pattern and therefore do not prevent a-helical coiled
coil formation.
Discussion
One of the hurdles in vaccine development against erythrocytic
stages of the parasite is the extensive polymorphism observed in
blood stage antigens. A function of polymorphic epitopes may be
to divert the effective response. In natural and artificially induced
humoral responses, the polymorphic regions of antigens were
found to be immunodominant [2,10,26], but it is not known
whether polymorphic regions are better or worse than conserved
regions as targets of protective immunity.
The fact that polymorphism is maintained in populations lead
to the question whether this is due to immune selection through
allele-specific protective responses. For several polymorphic
antigens immune selection has been confirmed [10,27]. Similarly,
SNPs were demonstrated to be under balancing selection, and the
Figure 2. Alignment pf P14 sequences amplified from 13 culture strains. A deletion of the GDINNMN amino acid motif was observed with a
frequency of 0.54 (7/13). In addition an imperfect repeat (GDINNIN) of this motif was detected with a frequency of 0.23 (3/13).
doi:10.1371/journal.pone.0005419.g002
Figure 3. Alignment of P83 sequences amplified from 13 culture strains. SNP in P83 at nt position 863 TRA results in an amino acid change
from Methionine (M) to a Lysine (K) at position 288 in PFC0345w gene product (red). This SNP was observed with a frequency of 0.38 (5/13). An
insertion of DMNIKEN amino acid motif (bold and underlined) was detected with a frequency of 0.31 (4/13).
doi:10.1371/journal.pone.0005419.g003
Conserved Coiled Coils
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new vaccine targets in known antigens [27] or in the entire
Plasmodium falciparum genome [3].
Conserved regions were found to be less antigenic and
immunogenic than polymorphic regions [6,10,26,28]. To investi-
gate whether conserved regions can elicit adequate protection, the
effect of antibody responses to both the conserved and polymor-
phic regions of MSP3 was measured [10]. Antibodies against both
regions were associated with a reduced risk to develop clinical
malaria [10]. Moreover, antibodies against the conserved epitopes
elicited in humans inhibited parasites growth in vitro as shown by
the antibody-dependent cellular inhibition assay [29] and lead to
rapid parasite clearance after injection to humanized mice [29,30].
During preclinical evaluation of new vaccine candidates, both
antigenicity and sequence conservation are generally determined.
We have shown that the majority of our candidates were both
conserved and antigenic. In sero-epidemiological surveys the most
peptides were found to be recognized by sera of adults from
malaria endemic countries [13] (own unpublished results).
Immunogenicity of most of the peptides investigated in more
detail was confirmed in mice or rabbits [13] (Olugbile,
unpublished results). It remains to be shown whether our described
strategy to select non-polymorphic epitopes for inclusion in a
vaccine will lead to greater efficacy in a field trial.
We analyzed the degree of conservation in predicted a-helical
coiled coil regions of all proteins expressed in the blood stages of
the parasite. Sequencing revealed that SNPs observed in field
samples did not seem to disturb the heptad motif and thus do not
destabilize the coiled coil structure. SNPs mostly occurred at
hydrophilic surface positions of the coil except for P83. It is likely
that SNPs located at surface positions result in a decreased
antibody response to the variant epitope and may lead to immune
evasion. However, the extent of polymorphism detected in our
candidates was very limited and thus might not create a major
limitation for vaccine efficiency.
Our sequence analysis revealed that both SNPs and LP were
preferentially observed in the a-helical coiled coil motifs containing
almost perfect tandem repeats. The perfect repeat units either
coincide with the 7-residue coiled coil repeat (e.g. P14, P45, P50,
P51, P64, P81, P83, P144, P166) or covering two or more heptad
repeats (e.g. P1, P94). This correlation between the repeats
perfection and polymorphism leads to a practical recommendation
for selection of vaccine candidates: when searching for a-helical
coiled coil regionswitha reduced levelofpolymorphism,one should
avoid regions with almost perfect tandem repeats.
a-helical coiled coil domains were found to be crucial for the
biological function of various proteins. Coiled coils have been
shown to be involved in oligomerization, protein-protein interac-
tion and complex formation. These features support many cellular
processes such as membrane fusion, protein transport and cell
motility [17]. But for the proteins investigated by it is not known
whether the putative coiled coil domains are of any functional
importance. If these domains play a role in protein function,
purifying selection might counteract diversification and polymor-
phism. Sequence conservation due to functional constraints was
reported from viral envelope proteins where the conserved region
was found at those positions of the coiled coil that are responsible
for protein-protein interaction [31].
Extensive polymorphism has been an issue for the most
promising blood stage vaccine candidates, such as apical
membrane antigen 1, MSP1 and 2 [6,32–35]. In the past, vaccine
research was focused on a limited number of vaccine candidates.
Due to recent disappointing results from clinical trials where a
number of vaccine candidates were not found to be immunogenic,
safe, or protective against artificial challenge [36–38], new
emphasis is laid upon the discovery of novel target antigens. If
more of the current candidates fail, additional antigens are
Figure 4. SNPs and LP of P83 sequences amplified in field samples from PNG and Tanzania. In PNG samples essentially only one SNP
(SNP1) at nt position 863 TRA results in an amino acid change from Methionine (M) to a Lysine (K) at position 288 in PFC0345w gene product. This
SNP was detected with a high frequency of 0.5 (4/8) and was also observed in culture strains. In Tanzanian samples 3 SNPs (SNP2, SNP3, SNP4;
bolded) and 2 LP (LPT2, LPT26; insertion indicated in bold) occurring with low frequencies of 0.04 (1/27) were detected.
doi:10.1371/journal.pone.0005419.g004
Table 3. Genetic diversity of P27, P90, P83, P8 and P77 in P.
falciparum positive field samples from Tanzania and Papua
New Guinea.
peptide Gene ID SNPs detected by sequencing of field samples
nt position frequency
type of
mutation
a–d
P27 PFF0165c conserved 46/46 (TZ)
conserved 17/17 (PNG)
P90 PFD0520c nt 195 TRC 4/23 (PNG) s
conserved 31/31
(TZ)
P77 PF08_0048 conserved 14/14 (TZ)
conserved 10/10 (PNG)
P8 PFB0145c nt 1817 CRT 1/33 (TZ) ns (T606I)
nt 1856 TRA 1/29 (PNG) ns (M619K)
P83 PFC0345w nt 863 TRA 4/8 (PNG) ns (M288K)
nt 999 ARC 1/27 (TZ) ns (E333D)
nt 976 ARG 1/27 (TZ) ns (N326D)
nt 937 ARC 1/27 (TZ) ns (M313L)
nt 843 ARC 1/27 (TZ) ns (K282Q)
nt 844 ARC 1/27 (TZ) ns (K282Q)
nt 823 1/27 (TZ) dup (DIIKN)
nt 885 1/27 (TZ) del (DMNIIKN)
anon synonymous (ns).
bsynonymous (s).
cdeletion (del).
dduplication (dup).
doi:10.1371/journal.pone.0005419.t003
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Peptide Protein Sequence Frequency Score
a
P1 PFA0170c 3D7:
VNNLDSTVNYMNSTGNNINNIVNNLDSTVNYMNSTGNNINNIVNNLDSTVNYMNSTGNNINNI 2.570
Hb3:
VNNLDSTVNYMNGTGNNINNIVNNLDSTVNYMNSTGNNINNIVNNLDSTVNYMNSTGNNINNI 1/15 2.570
P14 PFC0245c 3D7:
GMNNMNGDINNINGDINNMNGDINNMNGDINNMNGDINNMN 3.100
RO-33:
GMNNMNEDINNINGDINNMNGDINNMNGDINNMNGDINNMN 1/10 3.450
P17 PFD0110w 3D7:
EKKLDILKVNISNINNSLDKLK manual
b
GHANA1:
EKKLDILKANISNINNSLDKLK 1/11 manual
b
P23 3D7:
FQKVKEKAEIQKENIEKIKQEINTL manual
b
7G8;FCB;K1:
FQKVKEKAENQKENIEKIKQEINTL 4/10 manual
b
GHANA1:
FQKIKEKAENQKENIEKIKQEINTL 1/10 manual
b
P33 PF13_0277 3D7:
YIDDVDRDVENYDKGIANVDHHLNDVH 3.020
106_1;D6;Dd2;FCC-2;FCR3;GHANA1;Hb3;IT;K1;RO-33
YIDDVNRDVENYDKGIANVDHHLNDVH 10/12 3.080
P34 MAL13P1.336 3D7:
NMNNMNNNMNNMNNNMNNNMNNMNNMN 3.570
D6:
NMNNMNNNMNNMNNNMNNNMNNMNSMN 1/5 3.550
P36 PF14_0093 3D7:
SSNNLSDQINILNNNIQHINSTFNNLR 2.920
Senegal3404:
SSNNLSDQINILNNNIQHINSIFNNLR 1/8 2.730
P45 PF11_0207 3D7:
EEIKEEIKEVKEEIKEVKEEIKEVKEEIKEVKEEIKE 4.550
GHANA1:
EEVKEEIKEVKEEIKEVKEEIKEVKEEIKEVKEEIKE 1/2 4.550
P47 PFA0635c 3D7:
NHDTRINDYNKRLTEYNKRLTEYNKRLTEYTKRLNE 3.520
Hb3:
NHDTRINDYNKRLTEYNKRLTAYNKRLTEYTKRLNE 1/9 3.320
P50 PFL1605w 3D7:
KNDINVQLDDINVQLDDINVQLDDINIQLDEINLN 3.290
7G8:
KNDINVQLDDINVQLDDINIQLDDINIQLDEINLN 1/10 3.270
D10:
KNDINVQLDDINVQLDDINVQLDDINVQLDEINLN 1/13 3.310
P51 PFD0985w 3D7:
DNNVNNMDNNVNNVDNNVNNVDNNLNNVDNNVNN 3.950
Dd2:
DNNVNNVDNNVNNVDNNVNNVDNNLNNVDNNVNN 1/11 3.900
P54 MAL6P1.147 3D7:
DSMNNHKDDMNNYNDNINNYVESMNNYDDIMNK 2.470
Conserved Coiled Coils
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a
FCC-2:
DNMNNHKDDMNNYNDNINNYVESMNNYDDIMNK 1/9 2.470
GHANA1:
NSNNNHKDDMNNYNDNINNYVESMNNYDDIMNK 1/9 1.920
P64 MAL6P1.131 3D7:
NNFVNNKMNNMNNMKNNMNNMNNIMNNIMN 3.100
FCC-2:
NNFVNNKMNNMNNMKNNMNNMNNIMNNNMN 1/8 2.650
P81 PF07_0086 3D7:
NEMNKEVNKMNEEVNKMNEEVNKMNEEVNKMNKEVNKMDEEVNKMN 4.580
D10;D6;GHANA1;Santa Lucia:
NEMNKEVNKMNEEVNKMNEEVNKMNEEVNKMNEEVNKMDEEVNKMN 4/9 4.580
GHANA1:
NEMNKEVNKMNEEVNKMNEEVNKMNKEVNKMDKEVNKMDEEVNKMN 1/7 4.580
P83 PFC0345w 3D7:
QNKMENDMNIIKNDMNIMENDMNIMENDMNIIKNDMNIME 3.250
KDMNIIKNDMNIIKNNMNIIKNEMNIIKNV
D10;FCC-2;V1_S:
QNKMENDMNIIKNDMNIKENDMNIMENDMNIIKNDMNIME 4/9 3.220
KDMNIIKNDMNIIKNNMNIIKNEMNIIKNV
RO-33:
QNKMENDMNIIKNDMNIKENDMNIMENDMNIIKNDMNIIE 1/10 3.200
KDMNIIKNDMNIIKNNMNIIKNDMNIIKNV
P86 PFL1930w 3D7:
NFIKELELQIKNLNNEINTLNDMLKDSEEEIRMLNHTLEEK 3.710
7G8:
NFIKELELQIKNLNNEIKTLNDMLKDSEEEIRMLNHTLEEK 1/11 3.760
P94 PFD0970c 3D7:
ENINNMDEKINNVDEQNNNMDEKINNVDEKK 3.460
FCC-2:
ENINNMDEKINNVDEQNNNMDEKINNVDEKI 1/6 3.460
D10;K1:
ENINNMDEKKNKVDEQNNNMDEKINNVDEKK 4/7 2.990
D6;FCC-2:
ENINNMDEKINKVDEQNNNMDEKINNVDEKK 3/5 2.970
RO-33:
ENINNMDEKINKVDEQNNNIDEKINNVDEKK 3/6 3.480
P97 PFL0650c 3D7:
DTANNVSEMQKIIHTFSLDIKDFKILFEALTKSIQLLNDN 3.390
IENINKEIELLKKKIST
FCC-2:
DTANNVSEMQKIIHTFSLDIKDFKILFEALTKSIQLLNDN 1/8 3.140
IENINKEIELFKKKIST
P103 PFE0840c 3D7:
NNMNNININAYNILKDINKYRNIVNNLDH 2.310
Dd2;FCC-2
NNMNNININAYNVLKDINKYRNIVNNLDH 2/7 2.310
P116 PF13_0182 3D7:
RISNILFMLNNIKKEIENVKENILKYIDK 2.570
106_1;7G8;GHANA1;IT;Senegal3404;V1_S
Table 4. cont.
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PLoS ONE | www.plosone.org 9 May 2009 | Volume 4 | Issue 5 | e5419required for supplementing the vaccine pipeline. There is a great
demand to identify new antigens that are both, immunogenic and
conserved. It remains to be shown whether the strategy to include
non-polymorphic antigens in a vaccine formulation will increase
protection.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0005419.s001 (0.04 MB
DOC)
Peptide Protein Sequence Frequency Score
a
RISNILFMLNNIKKEIENVKENILKYIDR 6/11 2.570
P119 PF11_0240 3D7:
DNVEELNKDIENLNNEIHEIEKMWLFIKK 3.010
GHANA1:
DNVEELNKDIEILNNEIHEIEKMWLFIKK 1/8 2.770
P122 PFI1475w 3D7:
YDLSIYNKQLEEAHNLISVLEKRIDTLKK 2.930
D10;Dd2;FCC-2
YNLSIYNKQLEEAHNLISVLEKRIDTLKK 3/16 2.640
7G8;D10;Dd2;FCC-2;K1;RO-33;V1_S
YDLFIYNKQLEEAHNLISVLEKRIDTLKK 7/16 2.640
P134 PF14_0535 3D7:
KQIDLNINNIDDNKNNIDDHINNIDD 2.750
7G8:
KQIDLNINNIDDHINNIDDHINNIDD 1/7 3.060
P144 PF13_0210 3D7:
HDVNNYQHDVNNYQQDVNNYQHDVNNYQHDVNNYNH 2.470
Dd2;Hb3;RO-33;Senegal3403;V1_S
HDVNNYQHDVNNYQQDVNNYQHDVNNYQHDVNNYHH 4/5 2.470
P149 MAL13P1.252 3D7:
NLALNNLRNKLKLLQEDYNDLEKEYLYLKKSLSK 3.350
Dd2:
NLALNNLRNKLKLLQEDYNDLEKEYLYLKKGLSK 1/8 3.350
P154 PFL1205c 3D7:
QFIILMVKLLSNVYEIVKKINSLNNNYTYLYIN 2.680
7G8;D10;FCB;FCC2;GHANA1;Hb3;K1;Senegal3404
QFIILMVKLLSNVYEIEKKINSLNNNYTYLYIN 7/8 3.030
P156 PFD1030c 3D7:
KINSLKENIENMFDRIDNYIHEVISLKNFVNQ 2.820
K1:
KINSLKENIENMFDRIDNYIHVVISLKNFVNQ 1/8 2.460
P160 PF11_0268 3D7:
MNISEFETKITELKEDINKINFMMKDFESKF 3.170
7G8;D10;D6;Dd2;FCC-2;FCR3;GHANA1;Hb3;IT;K1;RO-33;Senegal3404;V1_S:
MNISEFETKITELKEDINKINFMMKAFESKF 13/13 3.020
P166 PFI1180w 3D7:
YYNNFDNYNNNFDNYNNNFDNYNNNFDNYN 2.420
GHANA1:
YNNNFDNYNNNFDNYNNNFDNYNNNFDNYN 1/9 2.420
aprofile score for a-helical coiled coil formation;
bprofile score was manually analyzed.
Positions of SNPs are indicated in bold.
doi:10.1371/journal.pone.0005419.t004
Table 4. cont.
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